廈鎢新能(688778.SH):成功開發出第二代低殘鹼、高比表的鋰鑭鋯氧LLZO
格隆匯12月30日丨廈鎢新能(688778.SH)在投資者互動平台表示,公司在固態電池上主要圍繞正極材料和固態電解質進行佈局:其中固態電解質方面,(1)公司通過結構改善,成功開發出第二代低殘鹼、高比表的鋰鑭鋯氧LLZO,應用在正極材料包覆、正負極添加劑;(2)公司開發出磷酸鈦鋁鋰LATP粉體和漿料等兩種規格體系,應用在正極材料包覆、隔膜塗覆,有效改善安全性。 硫化物技術路線固態電解質的部分痛點主要在於硫化鋰,由於其合成工藝比較複雜,價格昂貴。公司憑藉深厚的技術沉澱,開發出新的硫化鋰合成工藝,目前從小試、中試結果來看,技術指標良好,降本空間較大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.